Why the study?
To estimate the healthcare costs attributable to gastrointestinal bleeds in nonvalvular atrial fibrillation patients.
What are the healthcare costs attributable to gastrointestinal bleeds in patients with nonvalvular atrial fibrillation?
What are the healthcare costs attributable to gastrointestinal bleeds in patients with nonvalvular atrial fibrillation?
Gastrointestinal bleeds in patients with nonvalvular atrial fibrillation are associated with significant healthcare costs, primarily from inpatient visits, for up to 2 years following the event.
Answers are grounded in this paper and cite their sources.
GI bleeds drive persistent costs in NVAF; extends economic burden estimates but leaves open whether prevention alters expenditures.
Aim: To estimate the healthcare costs attributable to gastrointestinal (GI) bleeds in nonvalvular atrial fibrillation (NVAF) patients. Material & methods: A difference-in-differences approach was used in which NVAF patients suffering a (GI) bleed were propensity score matched to those not suffering a GI bleed, and the difference in healthcare costs in the year prior to the GI bleed and the subsequent 3 years was compared between the two groups. Results: The mean cost attributable to GI bleeds was £3989 (p < 0.0001) in the year of the bleed and £1816 (p = 0.001) in the subsequent year. Attributable costs arose primarily from inpatient visits. Conclusion: GI bleeds among NVAF patients are associated with significant healthcare costs up to 2 years following the bleed.
No takes yet. Share an insight, caveat, or question.
Ramagopalan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: